GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,960,209 | -32.6% | 8,432,773 | -2.2% | 0.00% | -25.0% |
| Q2 2023 | $47,424,119 | -38.4% | 8,622,567 | -51.8% | 0.00% | 0.0% |
| Q1 2023 | $76,968,824 | +119.7% | 17,899,726 | +100.8% | 0.00% | +33.3% |
| Q4 2022 | $35,029,391 | -25.5% | 8,913,331 | +0.7% | 0.00% | -40.0% |
| Q3 2022 | $47,003,000 | -16.3% | 8,851,683 | +3.4% | 0.01% | -16.7% |
| Q2 2022 | $56,172,000 | -10.5% | 8,562,941 | +0.1% | 0.01% | +20.0% |
| Q1 2022 | $62,763,000 | +3.8% | 8,550,767 | +0.2% | 0.01% | +25.0% |
| Q4 2021 | $60,437,000 | -71.7% | 8,536,462 | +0.2% | 0.00% | -76.5% |
| Q3 2021 | $213,523,000 | -6.6% | 8,517,087 | +0.3% | 0.02% | -5.6% |
| Q2 2021 | $228,516,000 | -5.1% | 8,495,022 | +0.4% | 0.02% | -14.3% |
| Q1 2021 | $240,889,000 | +18.3% | 8,464,109 | +17.9% | 0.02% | +16.7% |
| Q4 2020 | $203,577,000 | -7.5% | 7,180,864 | -2.6% | 0.02% | -18.2% |
| Q3 2020 | $220,063,000 | +52.6% | 7,373,381 | -0.0% | 0.02% | +37.5% |
| Q2 2020 | $144,187,000 | – | 7,373,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
| Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
| PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
| Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
| EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
| Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
| SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |